The 9th Annual Pain & Migraine Therapeutics Summit 2015

Topics

• Analysis of new drug discovery targets
• Review and analysis of key developmental stage therapies for nociceptive pain, neuropathic pain, migraine, back pain, fibromyalgia, cancer pain, arthritic pain, acute pain and chronic pain
• Real-time fMRI (functional magnetic resonance imaging) for pain
• Analysis and case studies of successful commercialization strategies for pain therapies
• Genome-wide association studies of pain
• Challenges of pain clinical trials
• Analysis of NGF antagonist clinical development programs
• Endpoints in pain clinical trials
• Abuse-resistant opioids in clinical development
• Molecular tools for dissecting pain pathways
• The future role of pharmacogenomics, biomarkers and translational research in the development of therapeutics for pain
• Sodium and calcium channel blockers in pre-clinical & clinical development
• Gene therapy for pain
• Clinical development status of longer-acting analgesics for post-operative pain
• Exploration and analysis of animal models for pain

Who should Attend

• Chief Scientific Officers, Scientists, Research Fellows, Professors, Chief Executive Officers, Research Directors and Chief Medical Officers
• Directors, Managers, VPs, Associates and Heads from the areas of: Drug development, New Product Planning, Pain research, Neuroscience clinical development, Pain management, Clinical development/research, Scientific Affairs, Drug delivery, Research, Pain management devices, Business development/licensing, Neuroscience drug discovery and Alliance management
• Academic institutions, Investment banks and venture capitalist firms and Consultancies